MKS Inc. Common Stock (MKSI) Stock Analysis
Market Closed
Sector: Technology · Industry: Industrial Instruments For Measurement, Display, And Control
AnalystsStrong Buy20 analystsWhat's happening with MKSI
Price History
5-Year Weekly Candlestick Chart
Profile
valuation, profitability, growth and financial health lag behind.
How is each axis scored?
- Valuation30/100 · Weak
- P/E vs own history (86th pct)0/25
- FCF yield (2.3%)5/25
- P/S (4.3x)20/25
- EV/EBIT (36.9x)5/25
- Growth45/100 · Weak
- Revenue CAGR (14.0%)20/25
- Net income CAGR (-4.2%)0/25
- EPS CAGR 5Y (-8.9%)0/25
- Fwd implied growth (250.1%)25/25
- Profitability42/100 · Weak
- ROIC (7.1%)5/25
- ROE (11.6%)12/25
- Net margin (8.0%)13/25
- Operating margin (13.9%)12/25
- Financial Health45/100 · Weak
- Altman Z (2.20)18/25
- Current ratio (1.11)12/25
- Interest coverage (3.3x)10/25
- Net cash / debt (D/A 40%)5/25
- Quality71/100 · Moderate
- Piotroski F (6/9)15/25
- Beneish M (-2.60)25/25
- FCF conversion (123%)25/25
- Margin stability (σ 21.9%)6/25
About MKS Inc. Common Stock
MKS Inc delivers foundational technology solutions for leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. Show more
The company provides instruments, components, subsystems, systems, process control solutions, and specialty chemicals technology that improve process performance and optimize productivity. Its solutions address challenges of miniaturization and complexity in device manufacturing, enabling increased power, speed, and feature enhancement. MKS Inc operates through three divisions: Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Materials Solutions Division (MSD). The company operates in the United States, which generates maximum revenue, as well as China and other countries.
Headquarters: ANDOVER, MA · Employees: 10,300 · Website ↗
Insider Transactions
Recent SEC Form 4 filings
- SellOpen market sale · filed 2026-09-02-300 sh2026-09-01
- BuyGrant / award · filed 2026-08-18+954 sh2026-08-17
- SellOpen market sale · filed 2026-08-17-10000 sh2026-08-14
- SellOpen market sale · filed 2026-08-04-457 sh2026-08-03
- SellOpen market sale · filed 2026-06-16-217 sh2026-06-12
+3 more recent filings
Key Metrics
Financial snapshot — pillar inputs plus per-share and market context
Valuation
30DP/E (TTM)56.0xD
Grade D: ExpensivePrice / TTM EPS (own statements) — vs own 5Y history: 8.3x–96.7x · 86th pct
P/FCF38.0xC
Grade C: ExpensivePrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield2.3%C
Grade C: LowTTM FCF / Market Cap — vs own 5Y history: 1.3%–10.9% · 9th pct
P/S (TTM)4.27xB
Grade B: FairPrice / TTM Revenue (own statements) — vs own 5Y history: 1.1x–7.8x · 90th pct
EV/EBIT36.9xD
Grade D: ExpensiveEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 7.8x–62.0x · 87th pct
EV/Sales4.7xB
Grade B: FairEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E16.0xB
Grade B: FairPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio6.19xC
Grade C: ExpensivePrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio1.19B
Grade B: FairFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield0.36%A
Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio20.0%A
Grade A: SafeDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
42D+ROIC7.1%D
Grade D: LowNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE11.6%C
Grade C: AverageReturn on Equity. Neg. equity = heavy buybacks
ROA5.0%D
Grade D: WeakReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin8.0%C
Grade C: AverageNet Income / Revenue
Operating Margin13.9%C
Grade C: AverageTTM EBIT / TTM Revenue
Gross Margin46.6%C
Grade C: AverageGross Profit / Revenue
FCF Margin9.9%C
Grade C: AverageFCF / Revenue
True FCF Margin8.6%C
Grade C: AverageTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Financial Health
45D+Altman Z-Score2.20C
Grade C: Gray zoneBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio1.11xC
Grade C: OkCurrent Assets/Liabilities
Quick Ratio1.71xA
Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage3.3xC
Grade C: OkEBIT/Interest. >10 Strong
Debt Repayment8.7yC
Grade C: AverageYears to repay net debt via FCF
Net Debt/EBIT6.1xD
Grade D: HighLeverage. <2x Low, >4x High
Debt/Equity1.44xC
Grade C: MedDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt0.14xD
Grade D: ThinCash covers how much of total debt. >1 = could repay all debt from cash
Growth
45D+Revenue CAGR14.0%C
Grade C: OkCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR-4.2%D
Grade D: LowCompound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)-8.9%D
Grade D: LowCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth250.1%A
Grade A: HighImplied 1Y EPS growth from forward P/E vs our TTM EPS. Sparse — only where forward estimates exist
Dilution (5Y)+27.9%D
Grade D: DilutiveShare count change over 5Y
SBC / Net Income15.9%C
Grade C: MedStock-based comp/Net income. >30% = dilution risk
SBC / Revenue1.3%A
Grade A: LowTTM stock-based comp / TTM Revenue
Quality
71B+Piotroski F-Score6/9C
Grade C: AverageFinancial strength 0–9. >7 Strong
Beneish M-Score-2.60A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion122.9%A
Grade A: StrongFCF / Net Income
Margin Stability21.9%D
Grade D: VolatileEBIT margin std deviation. Lower = stable
Capex / Revenue3.8%A
Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.45xD
Grade D: LowRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
More metrics — Per Share, Balance Sheet, MarketHide additional metrics
Per Share
EPS (TTM)$4.60
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$10.04
Cash & short-term investments per share (Finnhub)
Book Value / Share$40.46
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$4.05B
Total debt obligations (short + long term)
Cash & Equiv.$569.00M
Cash and short-term investments
Net Debt$3.48B
Total Debt minus Cash. Negative = Net Cash position
Total Equity$2.81B
Shareholders' equity (book value)
Asset / Liability1.48xC
Grade C: AdequateTotal Assets / Total Liabilities
Market
Market Cap$17.41B
Current Market Capitalization
Beta2.10D
Grade D: High volatilityPrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
Takeaway
Takes ~8.7 years to repay net debt from free cash flow. · Current P/E of 56.0x sits at the 86th percentile of its historical range.
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Mar 2026 · Ratio snapshot Sep 25, 2026
Key Insights: MKS Inc. Common Stock (MKSI)
Piotroski F-Score of 6/9 indicates mixed fundamentals for MKS Inc. Common Stock. Altman Z-Score of 2.20 falls in the grey zone (1.81–2.99) — financial distress is unlikely but not ruled out. Beneish M-Score of -2.60 suggests a low likelihood of earnings manipulation.
- Takes ~8.7 years to repay net debt from free cash flow.
- At a valuation score of 30/100, MKSI trades at a premium to its historical multiples (P/E 56.0).
See how MKSI ranks on the Capex Tracker — top 50 capital spenders compared.
Recent Market Moves
See all MKSI moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Sep 21 | Pre-market | 260.93 | +3.51% | 2.34 |
Frequently Asked Questions about MKSI
Is MKSI stock a buy right now?
PreMarketPrice's quantitative model rates MKS Inc. Common Stock's financial health at 45/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is MKSI stock overvalued?
MKS Inc. Common Stock trades at a trailing P/E of 56.0 and our valuation score rates it 30/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does MKS Inc. Common Stock report earnings?
No confirmed earnings date is currently scheduled for MKSI. The Earnings section lists recent reports and updates as dates are announced.
What sector does MKS Inc. Common Stock operate in?
MKS Inc. Common Stock operates in the Technology sector, within the Industrial Instruments For Measurement, Display, And Control industry. The Related Stocks section lists sector peers for comparison.
What does MKS Inc. Common Stock do?
MKS Inc delivers foundational technology solutions for leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications.
About MKS Inc. Common Stock (MKSI) Stock
MKS Inc. Common Stock (MKSI) is a US-listed stock operating in the Technology sector, specifically the Industrial Instruments For Measurement, Display, And Control industry. Real-time pricing data for MKS Inc. Common Stock is available on this page with a market capitalization of $17.4 billion. The financial health score for MKSI is 45/100, which indicates moderate financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for MKSI stock.
MKSI Stock Analysis & Key Metrics
On PreMarketPrice, you can track MKS Inc. Common Stock (MKSI) across multiple dimensions:
- Pre-market price & movement: Real-time MKSI stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for MKSI with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for MKS Inc. Common Stock across multiple reporting periods.
- Financial health score: A composite score of 45/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for MKSI.
- Sector peers: Compare MKSI against 10 other technology stocks on key financial metrics.
Is MKSI a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate MKS Inc. Common Stock (MKSI) as an investment. The financial health score of 45/100 suggests moderate financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.MKS Inc. Common Stock (MKSI) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.